Wells Fargo’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-144
| Closed | -$383 | – | 7225 |
|
|
2024
Q1 | $383 | Buy |
144
+3
| +2% | +$8 | ﹤0.01% | 5949 |
|
|
2023
Q4 | $334 | Buy |
141
+7
| +5% | +$17 | ﹤0.01% | 6032 |
|
|
2023
Q3 | $188 | Buy |
134
+13
| +11% | +$18 | ﹤0.01% | 6227 |
|
|
2023
Q2 | $367 | Sell |
121
-4,982
| -98% | -$15.1K | ﹤0.01% | 6240 |
|
|
2023
Q1 | $31.9K | Buy |
5,103
+4,801
| +1,590% | +$30K | ﹤0.01% | 5108 |
|
|
2022
Q4 | $1.84K | Buy |
+302
| New | +$1.84K | ﹤0.01% | 5702 |
|
|
2022
Q3 | – | Sell |
-285
| Closed | -$4K | – | 7292 |
|
|
2022
Q2 | $4K | Sell |
285
-926
| -76% | -$13K | ﹤0.01% | 5834 |
|
|
2022
Q1 | $14K | Sell |
1,211
-10,715
| -90% | -$124K | ﹤0.01% | 5812 |
|
|
2021
Q4 | $211K | Buy |
11,926
+11,880
| +25,826% | +$210K | ﹤0.01% | 4870 |
|
|
2021
Q3 | $1K | Sell |
46
-93
| -67% | -$2.02K | ﹤0.01% | 6505 |
|
|
2021
Q2 | $3K | Sell |
139
-4,077
| -97% | -$88K | ﹤0.01% | 6150 |
|
|
2021
Q1 | $131K | Buy |
+4,216
| New | +$131K | ﹤0.01% | 5033 |
|